AJG Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Arthur J. Gallagher & Co. is not a strong buy for a beginner investor with a long-term strategy at this time. While the stock has shown recent price appreciation and positive technical indicators, the financial performance shows significant declines in key metrics such as net income, EPS, and gross margin. Additionally, hedge funds are selling heavily, and Congress members have shown a cautious attitude with more sale transactions. The options data suggests bearish sentiment, and recent insider activity includes a planned sale by an executive. While analysts maintain positive ratings, the reduced price targets reflect cautious optimism. Given these mixed signals, holding off on buying this stock is the most prudent decision for now.
The MACD is positive and expanding, indicating bullish momentum. RSI is neutral at 67.169, and moving averages are converging, suggesting no strong trend. The stock is trading near its resistance level of 229.391, with key support at 221.115. Overall, the technical indicators show moderate bullishness but no strong buy signal.
Recent acquisition of Krose GmbH, expanding European market presence.
Analysts maintain positive ratings, with upgrades from Mizuho and price targets still above the current price.
Hedge funds are selling heavily, with a 5037.71% increase in selling activity.
Congress members have sold shares recently, indicating caution.
Insider activity includes a planned sale by an executive.
Financial performance shows significant declines in net income (-41.50% YoY), EPS (-47.32% YoY), and gross margin (-8.45% YoY).
Options data indicates bearish sentiment with a high put-call volume ratio.
In Q4 2025, revenue increased by 33.59% YoY to $3.63 billion, but net income dropped by 41.50% YoY to $151.1 million. EPS fell by 47.32% YoY to 0.59, and gross margin declined by 8.45% YoY to 34.66%. These figures indicate strong revenue growth but significant profitability challenges.
Analysts maintain generally positive ratings, with recent upgrades from Mizuho to Outperform and price targets ranging from $226 to $298. However, most price targets have been reduced recently, reflecting cautious optimism amid sector challenges.
